Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flutamide for Gonadotropin Secretion in PCOS
NCT04597099Phase 1Unknown
- Sponsor
- University of Virginia
- Start
- Oct 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in polycystic ovary syndrome (PCOS) comparing Flutamide with Placebo (2 arms). Primary endpoint: Change in mean FSH concentration with progesterone administration at 4 weeks. Status: unknown.
02
Drugs
flutamide
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT04597099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04597099.